Insider Transactions in Q3 2025 at Castle Biosciences Inc (CSTL)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 02
2025
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
1,339
-1.96%
|
$30,797
$23.93 P/Share
|
|
Aug 27
2025
|
Kristen M Oelschlager Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
30,684
-9.36%
|
$644,364
$21.86 P/Share
|
|
Aug 15
2025
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
1,339
-1.92%
|
$26,780
$20.04 P/Share
|
|
Aug 13
2025
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
43,019
-38.17%
|
$817,361
$19.5 P/Share
|
|
Aug 08
2025
|
Tobin W Juvenal Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,294
-4.83%
|
$81,586
$19.36 P/Share
|
|
Aug 08
2025
|
Tobin W Juvenal Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,640
+10.7%
|
-
|
|
Aug 08
2025
|
Kristen M Oelschlager Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,804
-1.61%
|
$53,276
$19.36 P/Share
|
|
Aug 08
2025
|
Kristen M Oelschlager Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,640
+5.74%
|
-
|
|
Aug 08
2025
|
Frank Stokes Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,356
-8.21%
|
$82,764
$19.36 P/Share
|
|
Aug 08
2025
|
Frank Stokes Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,744
+15.51%
|
-
|
|
Aug 08
2025
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
23,972
-17.54%
|
$455,468
$19.36 P/Share
|
|
Aug 08
2025
|
Derek J Maetzold Pres. & Chief Exec. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
66,991
+32.89%
|
-
|